AQR Capital Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-73,546
| Closed | -$6.25M | – | 2309 |
|
|
2020
Q3 | $6.25M | Sell |
73,546
-61,481
| -46% | -$3.11M | 0.01% | 728 |
|
|
2020
Q2 | $4.79M | Buy |
135,027
+109,567
| +430% | +$3.2M | 0.01% | 803 |
|
|
2020
Q1 | $343K | Buy |
+25,460
| New | +$428K | ﹤0.01% | 1722 |
|
|
2019
Q2 | – | Sell |
-18,819
| Closed | -$362K | – | 2238 |
|
|
2019
Q1 | $362K | Sell |
18,819
-43,134
| -70% | -$695K | ﹤0.01% | 1905 |
|
|
2018
Q4 | $884K | Sell |
61,953
-20,842
| -25% | -$414K | ﹤0.01% | 1558 |
|
|
2018
Q3 | $1.73M | Sell |
82,795
-2,800
| -3% | -$66.3K | ﹤0.01% | 1467 |
|
|
2018
Q2 | $2.03M | Sell |
85,595
-6,090
| -7% | -$122K | ﹤0.01% | 1414 |
|
|
2018
Q1 | $1.34M | Sell |
91,685
-11,647
| -11% | -$190K | ﹤0.01% | 1546 |
|
|
2017
Q4 | $1.67M | Buy |
103,332
+8,067
| +8% | +$95.2K | ﹤0.01% | 1453 |
|
|
2017
Q3 | $1.33M | Buy |
95,265
+16,250
| +21% | +$162K | ﹤0.01% | 1559 |
|
|
2017
Q2 | $698K | Buy |
79,015
+15,389
| +24% | +$108K | ﹤0.01% | 1781 |
|
|
2017
Q1 | $412K | Buy |
+63,626
| New | +$322K | ﹤0.01% | 1940 |
|
|
2015
Q1 | – | Sell |
-16,500
| Closed | -$79K | – | 2375 |
|
|
2014
Q4 | $79K | Sell |
16,500
-31,200
| -65% | -$123K | ﹤0.01% | 2469 |
|
|
2014
Q3 | $177K | Sell |
47,700
-36,500
| -43% | -$123K | ﹤0.01% | 2380 |
|
|
2014
Q2 | $307K | Buy |
84,200
+1,200
| +1% | +$4.41K | ﹤0.01% | 2205 |
|
|
2014
Q1 | $349K | Buy |
83,000
+26,600
| +47% | +$132K | ﹤0.01% | 2202 |
|
|
2013
Q4 | $259K | Hold |
56,400
| – | – | ﹤0.01% | 2354 |
|
|
2013
Q3 | $349K | Buy |
56,400
+25,400
| +82% | +$146K | ﹤0.01% | 2149 |
|
|
2013
Q2 | $169K | Buy |
+31,000
| New | +$102K | ﹤0.01% | 2233 |
|
AQR Capital Management's IMMU Position: Q4 2020 in Review
AQR Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 73,546 shares — an estimated $6.25M sold.
AQR Capital Management first reported a position in IMMU in Q2 2013 and held it in 19 quarters. The position peaked at $6.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- AQR Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- AQR Capital Management sold 73,546 Immunomedics Inc shares in Q4 2020, an estimated $6.25M.
- AQR Capital Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 19 quarters.
- AQR Capital Management's Immunomedics Inc position peaked at $6.25M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.